• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Shionogi-ViiV Healthcare LLC - Articles and news items

GlaxoSmithKline logo

Shionogi-ViiV Healthcare announces completion of initial clinical registration package for dolutegravir in HIV

Industry news, News / 4 October 2012 / GlaxoSmithKline

Dolutegravir is not yet approved as a treatment for HIV…

GlaxoSmithKline logo
GlaxoSmithKline logo

Shionogi-ViiV Healthcare announces initial data from pivotal phase III study of dolutegravir in HIV

Industry news, News / 2 April 2012 / GlaxoSmithKline

SPRING-2 study meets primary endpoint of non-inferiority of dolutegravir…

 

Webinar: Different thermal analysis techniques to measure the glass transitionWATCH NOW
+ +